Association between Consumption of Artificial Sweeteners and Breast Cancer Risk: A Systematic Review and Meta-Analysis of Observational Studies

References

• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2021;71(3):209–49. doi: 10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• McTiernan A, Porter P, Potter JD. Breast cancer prevention in countries with diverse resources. Cancer. 2008;113(S8):2325–30. doi: 10.1002/cncr.23829
   PubMed Web of Science ®Google Scholar
• Weihrauch MR, Diehl V. Artificial sweeteners–do they bear a carcinogenic risk? Ann Oncol. 2004;15(10):1460–5. doi: 10.1093/annonc/mdh256
   PubMed Web of Science ®Google Scholar
• Kamenickova A, Pecova M, Bachleda P, Dvorak Z. Effects of artificial sweeteners on the AhR- and GR-dependent CYP1A1 expression in primary human hepatocytes and human cancer cells. Toxicol in Vitro. 2013;27(8):2283–8. doi: 10.1016/j.tiv.2013.10.001
   PubMed Web of Science ®Google Scholar
• Imamura F, et al. Consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: systematic review, meta-analysis, and estimation of population attributable fraction. BMJ. 2015;351:h3576.
   PubMed Web of Science ®Google Scholar
• Te Morenga L, Mallard S, Mann J. Dietary sugars and body weight: systematic review and meta-analyses of randomised controlled trials and cohort studies. BMJ. 2012;346:e7492–e7492. doi: 10.1136/bmj.e7492
   PubMed Web of Science ®Google Scholar
• Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4(8):579–91. doi: 10.1038/nrc1408
   PubMed Web of Science ®Google Scholar
• Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D. Diabetes and cancer: a consensus report. Diabetes Care. 2010;33(7):1674–85. doi: 10.2337/dc10-0666
   PubMed Web of Science ®Google Scholar
• Elliott SS, Keim NL, Stern JS, Teff K, Havel PJ. Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr. 2002;76(5):911–22
   PubMed Web of Science ®Google Scholar
• WHO guidelines approved by the guidelines review committee, in guideline: Sugars intake for adults and children. Geneva: World Health Organization; 2015. Copyright © World Health Organization, 2015..
   Google Scholar
• Sakurai M, Nakamura K, Miura K, Takamura T, Yoshita K, Nagasawa SY, Morikawa Y, Ishizaki M, Kido T, Naruse Y, et al. Sugar-sweetened beverage and diet soda consumption and the 7-year risk for type 2 diabetes mellitus in middle-aged Japanese men. Eur J Nutr. 2014;53(4):1137–8. doi: 10.1007/s00394-014-0681-4
   PubMed Web of Science ®Google Scholar
• Debras C, Chazelas E, Srour B, Druesne-Pecollo N, Esseddik Y, Szabo de Edelenyi F, Agaësse C, De Sa A, Lutchia R, Gigandet S, et al. Artificial sweeteners and cancer risk: Results from the NutriNet-Santé population-based cohort study. PLoS Med. 2022;19(3):e1003950. doi: 10.1371/journal.pmed.1003950
   PubMed Web of Science ®Google Scholar
• Scharf RJ, DeBoer MD. Sugar-sweetened beverages and children’s health. Annu Rev Public Health. 2016;37(1):273–93. doi: 10.1146/annurev-publhealth-032315-021528
   PubMed Web of Science ®Google Scholar
• Bucher Della Torre S, Keller A, Laure Depeyre J, Kruseman M. Sugar-sweetened beverages and obesity risk in children and adolescents: A systematic analysis on how methodological quality may influence conclusions. J Acad Nutr Diet. 2016;116(4):638–59. doi: 10.1016/j.jand.2015.05.020
   PubMed Web of Science ®Google Scholar
• Vos MB, Kaar JL, Welsh JA, Van Horn LV, Feig DI, Anderson CA, Patel MJ, Cruz Munos J, Krebs NF, Xanthakos SA, et al. Added sugars and cardiovascular disease risk in children: A scientific statement from the American Heart Association. Circulation. 2017;135(19):e1017–e1034. doi: 10.1161/CIR.0000000000000439
   PubMed Web of Science ®Google Scholar
• Mooradian AD, Smith M, Tokuda M. The role of artificial and natural sweeteners in reducing the consumption of table sugar: A narrative review. Clin Nutr ESPEN. 2017;18:1–8. doi: 10.1016/j.clnesp.2017.01.004
   PubMed Web of Science ®Google Scholar
• Qurrat Ul A, Khan SA. Artificial sweeteners: safe or unsafe? J Pak Med Assoc. 2015;65(2):225–7.
   PubMed Web of Science ®Google Scholar
• Gallus S, Scotti L, Negri E, Talamini R, Franceschi S, Montella M, Giacosa A, Dal Maso L, La Vecchia C. Artificial sweeteners and cancer risk in a network of case-control studies. Ann Oncol. 2007;18(1):40–4. doi: 10.1093/annonc/mdl346
   PubMed Web of Science ®Google Scholar
• Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA, PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1. doi: 10.1186/2046-4053-4-1
   PubMed Web of Science ®Google Scholar
• Hodge AM, Bassett JK, Milne RL, English DR, Giles GG. Consumption of sugar-sweetened and artificially sweetened soft drinks and risk of obesity-related cancers. Public Health Nutr. 2018;21(9):1618–26. doi: 10.1017/S1368980017002555
   PubMed Web of Science ®Google Scholar
• Romanos-Nanclares A, Collins LC, Hu FB, Willett WC, Rosner BA, Toledo E, Eliassen AH. Sugar-sweetened beverages, artificially sweetened beverages, and breast cancer risk: Results from 2 prospective US cohorts. J Nutr. 2021;151(9):2768–79. doi: 10.1093/jn/nxab172
   PubMed Web of Science ®Google Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5. doi: 10.1007/s10654-010-9491-z
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.
   PubMed Web of Science ®Google Scholar
• Peters JL. Comparison of two methods to detect publication bias in meta-analysis. JAMA. 2006;295(6):676–80. doi: 10.1001/jama.295.6.676
   PubMed Web of Science ®Google Scholar
• Ewertz M, Gill C. Dietary factors and breast-cancer risk in Denmark. Int J Cancer. 1990;46(5):779–84. doi: 10.1002/ijc.2910460505
   PubMed Web of Science ®Google Scholar
• Tandel KR. Sugar substitutes: Health controversy over perceived benefits. J Pharmacol Pharmacother. 2011;2(4):236–43.
   PubMedGoogle Scholar
• Augustin LSA, Dal Maso L, La Vecchia C, Parpinel M, Negri E, Vaccarella S, Kendall CWC, Jenkins DJA, Franceschi S. Dietary glycemic index and glycemic load, and breast cancer risk: a case-control study. Ann Oncol. 2001;12(11):1533–8. doi: 10.1023/A:1013176129380
   PubMed Web of Science ®Google Scholar
• Potischman N, Coates RJ, Swanson CA, Carroll RJ, Daling JR, Brogan DR, Gammon MD, Midthune D, Curtin J, Brinton LA, et al. Increased risk of early-stage breast cancer related to consumption of sweet foods among women less than age 45 in the United States. Cancer Causes Control. 2002;13(10):937–46. doi: 10.1023/A:1021919416101
   PubMed Web of Science ®Google Scholar
• Tavani A, Giordano L, Gallus S, Talamini R, Franceschi S, Giacosa A, Montella M, La Vecchia C. Consumption of sweet foods and breast cancer risk in Italy. Ann Oncol. 2006;17(2):341–5. doi: 10.1093/annonc/mdj051
   PubMed Web of Science ®Google Scholar
• Witte JS, Ursin G, Siemiatycki J, Thompson WD, Paganini-Hill A, Haile RW. Diet and premenopausal bilateral breast cancer: a case-control study. Breast Cancer Res Treat. 1997;42(3):243–51. doi: 10.1023/A:1005710211184
   PubMed Web of Science ®Google Scholar
• Lubin JH, Burns PE, Blot WJ, Ziegler RG, Lees AW, Fraumeni JF. Dietary factors and breast cancer risk. Int J Cancer. 1981;28(6):685–9. doi: 10.1002/ijc.2910280605
   PubMed Web of Science ®Google Scholar
• Seely S, Horrobin DF. Diet and breast cancer: the possible connection with sugar consumption. Med Hypotheses. 1983;11(3):319–27. doi: 10.1016/0306-9877(83)90095-6
   PubMed Web of Science ®Google Scholar
• Roberts DL, Dive C, Renehan AG. Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med. 2010;61(1):301–16. doi: 10.1146/annurev.med.080708.082713
   PubMed Web of Science ®Google Scholar
• Klement RJ, Kämmerer U. Is there a role for carbohydrate restriction in the treatment and prevention of cancer? Nutr Metab (Lond). 2011;8(1):75. doi: 10.1186/1743-7075-8-75
   PubMed Web of Science ®Google Scholar
• Sparano JA, Wang M, Zhao F, Stearns V, Martino S, Ligibel JA, Perez EA, Saphner T, Wolff AC, Sledge GW, et al. Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer. Cancer. 2012;118(23):5937–46. doi: 10.1002/cncr.27527
   PubMed Web of Science ®Google Scholar
• De Bruijn KMJ, Arends LR, Hansen BE, Leeflang S, Ruiter R, van Eijck CHJ. Systematic review and meta-analysis of the association between diabetes mellitus and incidence and mortality in breast and colorectal cancer. Br J Surg. 2013;100(11):1421–9. doi: 10.1002/bjs.9229
   PubMed Web of Science ®Google Scholar
• Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, et al. Race, breast cancer subtypes, and survival in the Carolina breast cancer study. JAMA. 2006;295(21):2492–502. doi: 10.1001/jama.295.21.2492
   PubMed Web of Science ®Google Scholar
• Memon AA, Bennet L, Zöller B, Wang X, Palmer K, Sundquist K, Sundquist J. Circulating human epidermal growth factor receptor 2 (HER2) is associated with hyperglycaemia and insulin resistance. J Diabetes. 2015;7(3):369–77. doi: 10.1111/1753-0407.12184
   PubMed Web of Science ®Google Scholar
• Fernández-Real JM, et al. Serum HER-2 concentration is associated with insulin resistance and decreases after weight loss. Nutr Metab (Lond). 2010;7:14.
   PubMed Web of Science ®Google Scholar
• O'Donovan N, Crown J. EGFR and HER-2 antagonists in breast cancer. Anticancer Res. 2007;27(3A):1285–94.
   PubMed Web of Science ®Google Scholar
• Yue W, Yager JD, Wang J-P, Jupe ER, Santen RJ. Estrogen receptor-dependent and independent mechanisms of breast cancer carcinogenesis. Steroids. 2013;78(2):161–70.
   PubMed Web of Science ®Google Scholar
• Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst. 2005;97(22):1679–87.
   PubMed Web of Science ®Google Scholar
• Yılmaz S, Uçar A. A review of the genotoxic and carcinogenic effects of aspartame: does it safe or not? Cytotechnology. 2014;66(6):875–81.
   PubMed Web of Science ®Google Scholar
• Rycerz K, Jaworska-Adamu JE. Effects of aspartame metabolites on astrocytes and neurons. Folia Neuropathol. 2013;51(1):10–7.
   PubMed Web of Science ®Google Scholar
• Tan SLW, Chadha S, Liu Y, Gabasova E, Perera D, Ahmed K, Constantinou S, Renaudin X, Lee M, Aebersold R, et al. Class of environmental and endogenous toxins induces BRCA2 haploinsufficiency and genome instability. Cell. 2017;169(6):1105–18.e15. doi 10.1016/j.cell.2017.05.010
   PubMed Web of Science ®Google Scholar
• Sieri S, Krogh V. Dietary glycemic index, glycemic load and cancer: An overview of the literature. Nutr Metab Cardiovasc Dis. 2017;27(1):18–31. doi 10.1016/j.numecd.2016.09.014
   PubMed Web of Science ®Google Scholar